• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索与SARS-CoV感染结果相关的宿主基因多态性:对COVID-19个性化医疗的启示

Exploring Host Genetic Polymorphisms Involved in SARS-CoV Infection Outcomes: Implications for Personalized Medicine in COVID-19.

作者信息

Ramos-Lopez Omar, Daimiel Lidia, Ramírez de Molina Ana, Martínez-Urbistondo Diego, Vargas Juan A, Martínez J Alfredo

机构信息

Faculty of Medicine and Psychology, Autonomous University of Baja California, Tijuana, Baja California, Mexico.

Nutritional Control of the Epigenome Group, IMDEA Food, CEI UAM + CSIC, Madrid, Spain.

出版信息

Int J Genomics. 2020 Oct 19;2020:6901217. doi: 10.1155/2020/6901217. eCollection 2020.

DOI:10.1155/2020/6901217
PMID:33110916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7582067/
Abstract

OBJECTIVE

To systematically explore genetic polymorphisms associated with the clinical outcomes in SARS-CoV infection in humans.

METHODS

This comprehensive literature search comprised available English papers published in PubMed/Medline and SCOPUS databases following the PRISMA-P guidelines and PICO/AXIS criteria.

RESULTS

Twenty-nine polymorphisms located in 21 genes were identified as associated with SARS-CoV susceptibility/resistance, disease severity, and clinical outcomes predominantly in Asian populations. Thus, genes implicated in key pathophysiological processes such as the mechanisms related to the entry of the virus into the cell and the antiviral immune/inflammatory responses were identified.

CONCLUSIONS

Although caution must be taken, the results of this systematic review suggest that multiple genetic polymorphisms are associated with SARS-CoV infection features by affecting virus pathogenesis and host immune response, which could have important applications for the study and understanding of genetics in SARS-CoV-2/COVID-19 and for personalized translational clinical practice depending on the population studied and associated environments.

摘要

目的

系统探索与人类严重急性呼吸综合征冠状病毒(SARS-CoV)感染临床结局相关的基因多态性。

方法

按照系统评价与Meta分析方案报告规范(PRISMA-P)指南和PICO/AXIS标准,在PubMed/Medline和SCOPUS数据库中全面检索已发表的英文论文。

结果

在21个基因中发现了29个多态性,这些多态性主要在亚洲人群中与SARS-CoV易感性/抗性、疾病严重程度和临床结局相关。因此,确定了参与关键病理生理过程的基因,如与病毒进入细胞的机制以及抗病毒免疫/炎症反应相关的机制。

结论

尽管必须谨慎,但该系统评价的结果表明,多种基因多态性通过影响病毒发病机制和宿主免疫反应与SARS-CoV感染特征相关,这对于严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)/冠状病毒病(COVID-19)遗传学的研究和理解以及根据所研究人群和相关环境进行个性化转化临床实践可能具有重要应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6268/7582067/7b87350a602f/IJG2020-6901217.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6268/7582067/cb51d70ff766/IJG2020-6901217.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6268/7582067/7b87350a602f/IJG2020-6901217.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6268/7582067/cb51d70ff766/IJG2020-6901217.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6268/7582067/7b87350a602f/IJG2020-6901217.002.jpg

相似文献

1
Exploring Host Genetic Polymorphisms Involved in SARS-CoV Infection Outcomes: Implications for Personalized Medicine in COVID-19.探索与SARS-CoV感染结果相关的宿主基因多态性:对COVID-19个性化医疗的启示
Int J Genomics. 2020 Oct 19;2020:6901217. doi: 10.1155/2020/6901217. eCollection 2020.
2
Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.ACE2 和 TMPRSS2 基因的多态性和突变与 COVID-19 相关:系统评价。
Eur J Med Res. 2022 Feb 22;27(1):26. doi: 10.1186/s40001-022-00647-6.
3
The association of COVID-19 severity and susceptibility and genetic risk factors: A systematic review of the literature.COVID-19 严重程度和易感性及遗传风险因素的关联:文献系统综述。
Gene. 2022 Aug 20;836:146674. doi: 10.1016/j.gene.2022.146674. Epub 2022 Jun 14.
4
COVID-19 pandemic: Insights into genetic susceptibility to SARS-CoV-2 and host genes implications on virus spread, disease severity and outcomes.COVID-19 大流行:对 SARS-CoV-2 遗传易感性以及宿主基因对病毒传播、疾病严重程度和结果影响的见解。
Hum Antibodies. 2022;30(1):1-14. doi: 10.3233/HAB-211506.
5
Viral and Host Genetic and Epigenetic Biomarkers Related to SARS-CoV-2 Cell Entry, Infection Rate, and Disease Severity.与SARS-CoV-2细胞进入、感染率和疾病严重程度相关的病毒及宿主遗传和表观遗传生物标志物
Biology (Basel). 2022 Jan 23;11(2):178. doi: 10.3390/biology11020178.
6
The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.microRNAs 在调节人类细胞中 SARS-CoV-2 感染中的作用:系统评价。
Infect Genet Evol. 2021 Jul;91:104832. doi: 10.1016/j.meegid.2021.104832. Epub 2021 Apr 1.
7
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
8
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
9
Relevance between COVID-19 and host genetics of immune response.新型冠状病毒肺炎(COVID-19)与宿主免疫反应遗传学之间的相关性。
Saudi J Biol Sci. 2021 Nov;28(11):6645-6652. doi: 10.1016/j.sjbs.2021.07.037. Epub 2021 Jul 17.
10
Participation of Single-Nucleotide Variants in and in the Immune Response against SARS-CoV-2 Infection: A Systematic Review.单核苷酸变异在针对严重急性呼吸综合征冠状病毒2感染的免疫反应中的参与:一项系统综述。
Pathogens. 2023 Nov 6;12(11):1320. doi: 10.3390/pathogens12111320.

引用本文的文献

1
Genomic Landscape of Susceptibility to Severe COVID-19 in the Slovenian Population.斯洛文尼亚人群中严重 COVID-19 易感性的基因组景观。
Int J Mol Sci. 2024 Jul 12;25(14):7674. doi: 10.3390/ijms25147674.
2
COVID-19: An Overview of SARS-CoV-2 Variants-The Current Vaccines and Drug Development.新型冠状病毒肺炎(COVID-19):严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)变异株概述——当前疫苗和药物研发进展。
Biomed Res Int. 2023 Aug 29;2023:1879554. doi: 10.1155/2023/1879554. eCollection 2023.
3
Prognostic Value of (rs2069514 and rs762551) Polymorphisms in COVID-19 Patients.

本文引用的文献

1
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.COVID-19 患者的病理性炎症:单核细胞和巨噬细胞的关键作用。
Nat Rev Immunol. 2020 Jun;20(6):355-362. doi: 10.1038/s41577-020-0331-4. Epub 2020 May 6.
2
Genotyping coronavirus SARS-CoV-2: methods and implications.冠状病毒 SARS-CoV-2 的基因分型:方法与意义。
Genomics. 2020 Sep;112(5):3588-3596. doi: 10.1016/j.ygeno.2020.04.016. Epub 2020 Apr 27.
3
Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics).
COVID-19患者中(rs2069514和rs762551)多态性的预后价值
Balkan J Med Genet. 2023 Jul 31;26(1):35-42. doi: 10.2478/bjmg-2023-0005. eCollection 2023 Jul.
4
Host genetic polymorphisms involved in long-term symptoms of COVID-19.与 COVID-19 长期症状相关的宿主遗传多态性。
Emerg Microbes Infect. 2023 Dec;12(2):2239952. doi: 10.1080/22221751.2023.2239952.
5
Computational network analysis of host genetic risk variants of severe COVID-19.严重 COVID-19 宿主遗传风险变异的计算网络分析。
Hum Genomics. 2023 Mar 2;17(1):17. doi: 10.1186/s40246-023-00454-y.
6
An Interplay between Oxidative Stress (Lactate Dehydrogenase) and Inflammation (Anisocytosis) Mediates COVID-19 Severity Defined by Routine Clinical Markers.氧化应激(乳酸脱氢酶)与炎症(红细胞大小不均)之间的相互作用介导了由常规临床指标定义的新冠病毒疾病严重程度。
Antioxidants (Basel). 2023 Jan 20;12(2):234. doi: 10.3390/antiox12020234.
7
HBD-2 variants and SARS-CoV-2: New insights into inter-individual susceptibility.HBD-2 变异体和 SARS-CoV-2:个体易感性的新见解。
Front Immunol. 2022 Dec 9;13:1008463. doi: 10.3389/fimmu.2022.1008463. eCollection 2022.
8
Genetic polymorphisms associated with susceptibility to COVID-19 disease and severity: A systematic review and meta-analysis.与 COVID-19 疾病易感性和严重程度相关的遗传多态性:系统评价和荟萃分析。
PLoS One. 2022 Jul 6;17(7):e0270627. doi: 10.1371/journal.pone.0270627. eCollection 2022.
9
Potential protective effect against SARS-CoV-2 infection by APOE rs7412 polymorphism.APOE基因rs7412多态性对新型冠状病毒感染的潜在保护作用。
Sci Rep. 2022 May 4;12(1):7247. doi: 10.1038/s41598-022-10923-4.
10
Predictors of Covid-19 level of concern among older adults from the health and retirement study.预测老年人对新冠病毒担忧程度的因素:来自健康与退休研究。
Sci Rep. 2022 Mar 15;12(1):4396. doi: 10.1038/s41598-022-08332-8.
新型冠状病毒病(COVID-19):大流行(流行病学、发病机制及潜在治疗方法)
New Microbes New Infect. 2020 Apr 14;35:100679. doi: 10.1016/j.nmni.2020.100679. eCollection 2020 May.
4
Obesity and SARS-CoV-2: A population to safeguard.肥胖与新型冠状病毒肺炎:需要保护的人群。
Diabetes Metab Res Rev. 2020 Oct;36(7):e3325. doi: 10.1002/dmrr.3325. Epub 2020 Jun 11.
5
COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies.心脏病专家眼中的COVID-19:基础病毒学、流行病学、心脏表现及潜在治疗策略
JACC Basic Transl Sci. 2020 Apr 10;5(5):518-536. doi: 10.1016/j.jacbts.2020.04.002. eCollection 2020 May.
6
Anti-IL6R role in treatment of COVID-19-related ARDS.抗白细胞介素6受体在治疗新型冠状病毒肺炎相关急性呼吸窘迫综合征中的作用
J Transl Med. 2020 Apr 14;18(1):165. doi: 10.1186/s12967-020-02333-9.
7
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.新型冠状病毒病中“细胞因子风暴”的发病机制与治疗。
J Infect. 2020 Jun;80(6):607-613. doi: 10.1016/j.jinf.2020.03.037. Epub 2020 Apr 10.
8
Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.冠状病毒 COV-19/SARS-CoV-2 对女性的影响小于男性:病毒感染的临床反应。
J Biol Regul Homeost Agents. 2020;34(2):339-343. doi: 10.23812/Editorial-Conti-3.
9
How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.如何降低冠状病毒-19(CoV-19 或 SARS-CoV-2)感染和白细胞介素-1(IL-1)介导的肺部炎症的可能性。
J Biol Regul Homeost Agents. 2020;34(2):333-338. doi: 10.23812/Editorial-Conti-2.
10
Emerging coronaviruses: Genome structure, replication, and pathogenesis.新兴冠状病毒:基因组结构、复制和发病机制。
J Med Virol. 2020 Apr;92(4):418-423. doi: 10.1002/jmv.25681. Epub 2020 Feb 7.